AVNS Q1 2023 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$159M-19.3% YoY

Gross Profit

$91M57.4% margin

Operating Income

$6M3.5% margin

Net Income

-$500,000-0.3% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-12.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$436M

Stockholders' Equity

$1.3B

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$159M	$197M	-19.3%
Gross Profit	$91M	$107M	-14.3%
Operating Income	$6M	$13M	-58.0%
Net Income	-$500,000	$5M	-109.3%

Revenue Segments

Chronic Care

$121M32%

Digestive health

$89M23%

Pain Management

$71M18%

Interventional pain

$36M9%

Acute pain

$35M9%

Respiratory health

$32M8%